0000899243-21-026535.txt : 20210629 0000899243-21-026535.hdr.sgml : 20210629 20210629150010 ACCESSION NUMBER: 0000899243-21-026535 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210625 FILED AS OF DATE: 20210629 DATE AS OF CHANGE: 20210629 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bernard Thierry CENTRAL INDEX KEY: 0001815490 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 211057620 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-25 0 0001492674 T2 Biosystems, Inc. TTOO 0001815490 Bernard Thierry 101 HARTWELL AVE LEXINGTON MA 02421 1 0 0 0 Restricted Stock Units 2021-06-25 4 A 0 73224 0.00 A Common Stock 73224 73224 D Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. The restricted stock units vest in one installment on the earlier of (i) June 25, 2022 and (ii) the date of the next annual meeting of stockholders. /s/ John Sprague, Attorney-in-fact 2021-06-29